z-logo
Premium
Management of sickle cell disease in patients undergoing cardiac surgery
Author(s) -
Crawford Todd C.,
Carter Michael V.,
Patel Rina K.,
SuarezPierre Alejandro,
Lin Sophie Z.,
Magruder Jonathan Trent,
Grimm Joshua C.,
Cameron Duke E.,
Baumgartner William A.,
Mandal Kaushik
Publication year - 2017
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.13093
Subject(s) - medicine , hemoglobinopathy , disease , cardiac surgery , limiting , intensive care medicine , surgery , mechanical engineering , engineering
Sickle cell disease is a life‐limiting inherited hemoglobinopathy that poses inherent risk for surgical complications following cardiac operations. In this review, we discuss preoperative considerations, intraoperative decision‐making, and postoperative strategies to optimize the care of a patient with sickle cell disease undergoing cardiac surgery.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom